Evidence map›Paper›PMID 39003464›Full record

ArticleBMC cancer2024

Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study.

XiaoJun Li, YanShan Zhang, YanCheng Ye, SuQing Tian, TingChao Hu, HongYu Chai, TianE Zhang, Faxin Wen

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

XiaoJun Li *Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.
YanShan Zhang *Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.
YanCheng YeHeavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China. zlyyyyc@163.com.
SuQing TianDepartment of Radiation Oncology, Peking University Third Hospital, Beijing, 100191, China.
TingChao HuHeavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.
HongYu ChaiHeavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.
TianE ZhangHeavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.
Faxin WenHeavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, No. 31 Sanitary Lane, Haizang Road, Wuwei, 733000, Gansu Province, China.

Funding

Science and Technology Project of Gansu Province 22ZY1QH001
6 · The paper itself

Abstract

backgroundThis study aimed to compare the survival outcome and side effects in patients with primary high-grade glioma (HGG) who received carbon ion radiotherapy (CIRT) alone or as a boost strategy after photon radiation (photon + CIRT PATIENTS AND

methodsThirty-four (34) patients with histologically confirmed HGG and received CIRT alone or Photon + CIRT

resultsEight WHO grade 3 and 26 grade 4 patients were included in the analysis. The median PFS in the CIRT alone and Photon + CIRT

conclusionBoth CIRT alone and Photon + CIRT

Indexed as

GliomaHeavy Ion RadiotherapyPhotonsAdultAgedBrain NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm GradingProgression-Free SurvivalRetrospective StudiesTemozolomideTreatment OutcomeYoung AdultTemozolomideCarbon ion radiotherapyHigh-grade gliomaOverall survivalProgression-free survival

Identifiers

PMID39003464
PMCPMC11245814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.